Profile
M.
Shane Ray is President, Chief Executive Officer & Director at Hemanext, Inc. starting in 2026.
Former positions include Director-Pilot Operations at Encelle, Inc., Principal at Exactech, Inc., General Manager-Biologics at Resolve Surgical Technologies, Inc. in 2013, and Chief Marketing Officer at curasan AG.
Education includes an undergraduate degree from East Carolina University and an MBA from The University of North Carolina at Charlotte.
M. Ray active positions
| Companies | Position | Start |
|---|---|---|
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Develops anaerobic storage system that minimizes oxidative damage to red blood cells | Chief Executive Officer | 24/02/2026 |
Former positions of M. Ray
| Companies | Position | End |
|---|---|---|
| CURASAN AG | Sales & Marketing | - |
Encelle, Inc.
Encelle, Inc. Medical SpecialtiesHealth Technology Engages in clinical research and development of bioartificial pancreas and drug-delivery systems for diabetes | Corporate Officer/Principal | - |
| EXACTECH, INC. | Corporate Officer/Principal | - |
Resolve Surgical Technologies, Inc.
Resolve Surgical Technologies, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets spinal & orthopedic implants and instruments | Corporate Officer/Principal | - |
Training of M. Ray
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Exactech, Inc.
Exactech, Inc. Medical SpecialtiesHealth Technology Manufactures and sells orthopedic implant devices for joint replacement | Health Technology |
Encelle, Inc.
Encelle, Inc. Medical SpecialtiesHealth Technology Engages in clinical research and development of bioartificial pancreas and drug-delivery systems for diabetes | Health Technology |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Develops anaerobic storage system that minimizes oxidative damage to red blood cells | Health Technology |
Resolve Surgical Technologies, Inc.
Resolve Surgical Technologies, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets spinal & orthopedic implants and instruments | Health Technology |
curasan AG
curasan AG Medical SpecialtiesHealth Technology Develops, manufactures and distributes biomaterials for bone & tissue regeneration | Health Technology |
East Carolina University
East Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- M. Ray
















